Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease
暂无分享，去创建一个
L. Dieleman | R. Fedorak | K. Kroeker | L. Dieleman | B. Halloran | V. Huang | C. Ma | D. Fedorak | D. K. Fedorak | C. Ma | Darryl K. Fedorak | Richard N. Fedorak | Christopher Ma | Vivian Huang